ACVBP regimen
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for ACVBP regimen, covering 2007-07-13 to 2015-09-02. Get the full timeline:
Most recent: Clinical Trial Update: ACVBP Plus Rituximab in Patients Aged From 18 to 59 Years With High-risk Diffuse Large B-cell Lymphoma [Phase 2]